Newton, MA, United States of America

Scott Ogg

This inventor holds 4 USPTO granted patents. Top assignee: The General Hospital Corporation. Active years: 2001-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Scott Ogg. Retrieved from https://idiyas.com/inventor/scott-ogg-u9kr0kgw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 3.2

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2001-2008

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Scott Ogg: Innovator in Therapeutic and Diagnostic Tools

Introduction

Scott Ogg is a notable inventor based in Newton, MA (US), recognized for his contributions to the field of therapeutic and diagnostic tools. He holds a total of four patents, showcasing his innovative approach to addressing health conditions related to impaired glucose tolerance.

Latest Patents

Among his latest patents, Scott Ogg has developed novel genes and methods for screening therapeutics useful for treating impaired glucose tolerance conditions. These patents also include diagnostics and therapeutic compositions aimed at identifying or treating such conditions, highlighting his commitment to advancing medical science.

Career Highlights

Scott Ogg is affiliated with The General Hospital Corporation, where he applies his expertise in developing groundbreaking medical technologies. His work has significantly impacted the understanding and treatment of glucose tolerance issues, making him a key figure in this area of research.

Collaborations

Scott has collaborated with esteemed colleagues such as Gary B Ruvkun and Koutarou Kimura, further enhancing the scope and impact of his inventions.

Conclusion

Scott Ogg's innovative work in therapeutic and diagnostic tools exemplifies the vital role of inventors in advancing healthcare solutions. His contributions continue to pave the way for improved treatments for impaired glucose tolerance conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…